全文获取类型
收费全文 | 9802篇 |
免费 | 790篇 |
国内免费 | 209篇 |
专业分类
耳鼻咽喉 | 135篇 |
儿科学 | 376篇 |
妇产科学 | 222篇 |
基础医学 | 977篇 |
口腔科学 | 103篇 |
临床医学 | 921篇 |
内科学 | 1871篇 |
皮肤病学 | 238篇 |
神经病学 | 588篇 |
特种医学 | 483篇 |
外科学 | 1311篇 |
综合类 | 841篇 |
一般理论 | 3篇 |
预防医学 | 788篇 |
眼科学 | 192篇 |
药学 | 694篇 |
7篇 | |
中国医学 | 423篇 |
肿瘤学 | 628篇 |
出版年
2023年 | 66篇 |
2022年 | 129篇 |
2021年 | 213篇 |
2020年 | 177篇 |
2019年 | 126篇 |
2018年 | 180篇 |
2017年 | 142篇 |
2016年 | 160篇 |
2015年 | 252篇 |
2014年 | 271篇 |
2013年 | 368篇 |
2012年 | 538篇 |
2011年 | 516篇 |
2010年 | 361篇 |
2009年 | 382篇 |
2008年 | 447篇 |
2007年 | 510篇 |
2006年 | 454篇 |
2005年 | 362篇 |
2004年 | 326篇 |
2003年 | 297篇 |
2002年 | 255篇 |
2001年 | 248篇 |
2000年 | 211篇 |
1999年 | 172篇 |
1998年 | 103篇 |
1997年 | 87篇 |
1996年 | 76篇 |
1995年 | 76篇 |
1993年 | 66篇 |
1992年 | 156篇 |
1991年 | 144篇 |
1990年 | 136篇 |
1989年 | 153篇 |
1988年 | 157篇 |
1987年 | 151篇 |
1986年 | 157篇 |
1985年 | 170篇 |
1984年 | 105篇 |
1983年 | 108篇 |
1979年 | 106篇 |
1978年 | 68篇 |
1977年 | 70篇 |
1973年 | 72篇 |
1972年 | 61篇 |
1958年 | 105篇 |
1957年 | 108篇 |
1956年 | 81篇 |
1955年 | 84篇 |
1954年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
红花注射液治疗冠心病心绞痛、心肌缺血临床观察 总被引:17,自引:0,他引:17
目的:观察红花注射液治疗冠心病心绞痛、心肌缺血的临床疗效。方法:选择126例冠心病心绞痛、心肌缺血的病例,分红花组及丹参组,疗程两周,详细记录治疗前后的临床表现、心电图、血糖、血脂、血液流变学检查的变化。结果:红花、丹参均可明显改善冠心病心肌缺血相应的临床症状和心电图改变,以红花较显著。红花还有降血糖、血脂作用,显著改善血液流变指标。结论:红花注射液是治疗冠心病心绞痛、心肌缺血的理想药物。 相似文献
32.
目的:探讨颅内动脉狭窄血管内球囊支架成形术的可行性、安全性及其疗效。方法:17例患者术前3天给予阿司匹林300mg/天和噻氯吡啶250mg/天,6F(Envoy)导引导管放置到颈内动脉远段或椎动脉近颅底段,造影获得工作位,评价血管狭窄程度:狭窄率=(1-狭窄处管径/狭窄远端管径)×100%,微导丝在路途导引下通过颅内动脉狭窄段,向远端直至P2或M2段,确保足够的支撑力。选择支架大小的依据为狭窄远端正常血管的直径,导丝引导下支架通过狭窄部位,造影确定支架位置正确,充盈球囊至5~6大气压,支架释放后造影确认展开良好,回撤球囊,无并发症,操作完毕。随访3~10月。结果:17例患者颅内动脉狭窄处植入支架,技术成功100%,造影显示狭窄由术前(78.3±12.9)%降至术后(6.8±7.3)%,狭窄的动脉管径恢复,短期随访(3~10个月)显示很好临床效果。术中出现一例蛛网膜下腔少量出血(SAH),对症治疗痊愈。6例随访造影未见血管再狭窄。结论:颅内动脉狭窄支架植入增加血管内径,改善血流量,减轻临床症状,是一种安全、可行有效的治疗方法。 相似文献
33.
M J Rosenthal D Smith L Yaguez V Giampietro D Kerr E Bullmore M Brammer S C R Williams S A Amiel 《Diabetic medicine》2007,24(7):720-727
AIMS: Caffeine enhances counterregulatory responses to acute hypoglycaemia. Our aim was to explore its effects on cortical function, which are not known at present. METHODS: Regional brain activation during performance of the four-choice reaction time (4CRT) at different levels of complexity was measured using functional magnetic resonance imaging (fMRI) at euglycaemia (5 mmol/l) and hypoglycaemia (2.6 mmol/l) in the presence and absence of caffeine in six healthy right-handed men. RESULTS: During hypoglycaemia, caffeine enhanced adrenaline responses to hypoglycaemia (2.5 +/- 0.7 nmol/l to 4.0 +/- 1.0 nmol/l, P = 0.01) and restored the brain activation response to the non-cued 4CRT, the linear increases in regional brain activation associated with increased task complexity and the ability to respond to a cue that were lost in hypoglycaemia alone. CONCLUSIONS: Caffeine can sustain regional brain activation patterns lost in acute hypoglycaemia, with some restoration of cortical function and enhanced adrenaline responsiveness. A methodology has been established that may help in the development of therapies to protect against severe hypoglycaemia in insulin therapy for patients with diabetes and problematic hypoglycaemia. 相似文献
34.
Insulin inhibition of endothelial prostacyclin production 总被引:7,自引:0,他引:7
Graft thrombosis is a common cause of early graft failure in pancreatic transplantation, even in the absence of rejection. Altered endothelial cell (EC) production of thromboactive substances may play a primary role in this and other settings of thrombosis where intraluminal insulin concentrations are high. We therefore investigated the effect of insulin on EC production of prostacyclin (PGI2), a potent endogenous antagonist of platelet aggregation and vasodilator. Confluent monolayers of human umbilical vein endothelial cells (HUVEC) were incubated for 15 min in Hanks'/Hepes buffer containing 0, 50, 250, or 500 microU/ml of human insulin or 0, 500, 1000, or 2000 microU/ml of porcine insulin. PGI2 production was assessed by exposing the monolayers to either 20 microM arachidonic acid (stimulated) or arachidonic acid vehicle (basal) for an additional 15 min. Test buffers were then assayed by RIA for 6-keto-PGF1 alpha, the stable metabolite of PGI2. The results of these experiments indicate that human insulin inhibits both basal and arachidonic acid-stimulated production of PGI2 from HUVEC in a dose-dependent manner. Inhibition of stimulated production was significant at concentrations of 250-500 microU/ml. Porcine insulin also inhibited arachidonic acid-stimulated production of PGI2 from HUVEC in a dose-dependent manner. However, HUVEC were less sensitive to porcine insulin than to human insulin and a concentration of 2000 microU/ml was required for significant inhibition. We therefore conclude that insulin, in locally high concentrations, inhibits endothelial PGI2 production in vitro. The ability of insulin to alter the production of thromboresistant substances from endothelium may facilitate thrombosis in circumstances where counterregulatory mechanisms are disturbed by injury or transplantation. 相似文献
35.
Major fragment of soluble peptidoglycan released from growing Bordetella pertussis is tracheal cytotoxin. 总被引:5,自引:2,他引:3 下载免费PDF全文
R S Rosenthal W Nogami B T Cookson W E Goldman W J Folkening 《Infection and immunity》1987,55(9):2117-2120
Bordetella pertussis is known to release a factor which promotes the loss of ciliated respiratory epithelium and copurifies with a soluble peptidoglycan (PG) fragment termed tracheal cytotoxin (TCT). The objective of this study was to determine whether pertussis organisms turn over and release PG derivatives in addition to TCT. B. pertussis Tohama (phase III) was grown in liquid Stainer-Scholte medium containing [3H]diaminopimelic acid (DAP) to label PG specifically, washed to remove free label, and suspended in fresh medium without [3H]DAP. Molecular sieve chromatography of supernatants obtained from such cultures revealed a single included peak of 3H, the elution volume of which corresponded roughly to a disaccharide peptide monomer standard (ca. 10(3) daltons). This material (i) contained [3H]DAP in acid-hydrolyzable linkage, (ii) comigrated with 1,6-anhydro-N-acetylmuramic acid-containing disaccharide peptides on paper chromatography, (iii) was resistant to degradation by mild alkali, and (iv) was indistinguishable from authentic TCT by high-voltage paper electrophoresis and two reversed-phase high-performance liquid chromatography systems. Together, the data suggest that B. pertussis releases a markedly homogeneous set of PG fragments, consisting principally of TCT, and that TCT is possibly a nonreducing, anhydromuramic acid-containing fragment or a cyclic PG derivative. 相似文献
36.
G J Rosenthal W A Craig E Corsini M Taylor M I Luster 《Toxicology and applied pharmacology》1992,112(2):222-228
Pentamidine isethionate, an antiprotozoal agent with therapeutic value against Pneumocystis carinii pneumonia, has been used for over 30 years without a precise understanding of its mechanism of pharmacologic action. We have previously reported that pentamidine has the capacity to inhibit the release of cytokines from macrophages through a post-translational processing event. The present studies were undertaken to assess the ability of pentamidine to modulate the detrimental effects of murine endotoxemia, a disease with a pathophysiology clearly linked to host-produced cytokines. Under conditions where normal B6C3F1 mice succumbed to the lethal effects of endotoxin, mice pretreated with pentamidine were significantly protected from both mortality and loss of thermoregulatory control. The EC50 for protection from mortality by pentamidine was approximately 11.4 mg/kg. These observations correlated with decreased serum levels of tumor necrosis factor (TNF) and interleukin 6. Inhibition of cytokines was not manifested as part of a generalized inhibition of protein synthesis as demonstrated by the lack of significant modulation of serum albumin in pentamidine-treated animals. In addition to decreased serum concentrations of cytokines, lungs isolated from mice treated with both pentamidine and endotoxin exhibited a decreased release of TNF compared to lungs isolated from mice treated with vehicle and endotoxin. The lower levels of TNF released from lung tissue in pentamidine-treated mice correlated with a lesser degree of alveolar deterioration than was observed in vehicle-treated mice. These data indicate that following endotoxin administration, pentamidine has a protective and antiinflammatory role both systemically and in the lung and suggest that inhibition of inflammatory cytokines may be one mechanism operable in the therapeutic activity of the drug against P carinii pneumonia. 相似文献
37.
Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects 总被引:3,自引:0,他引:3
P. PORTINCASA † A. DI CIAULA V. PALMIERI G. P. VAN BERGE-HENEGOUWEN† G. PALASCIANO 《European journal of clinical investigation》1995,25(10):746-753
Abstract. Gallbladder stasis is frequent in obese subjects and may contribute to their increased risk for gallstone formation. The bile salt sequestrant cholestyramine acutely enhances postprandial gallbladder emptying in lean subjects, through dis-inhibition of a negative feedback between intraluminal bile salts and CCK release. In this study the effect of cholestyramine on both gallbladder and gastric antrum dynamics were studied by realtime ultrasonography in 12 obese and 15 lean subjects. For the acute study, on different days, subjects ingested a liquid meal (two egg yolks plus water 200 mL, 50 kJ) or a meal with 4g cholestyramine. Gallbladder emptying was impaired in obese patients who had significantly larger fasting gallbladder volume (39.4 ± 6.9 vs. 21.6 ± l.7mL, P <0.02), larger residual volume (12.3 ± 1.8 vs. 4.0 ± 0.5ml, P < 0.0006) and slower emptying time ( T /2: 33 ± 2 vs. 21 ± 2 min, P < 0.05) than lean subjects. Integrated antral emptying was also less in obese than lean subjects (5521 ± 578 vs. 7908 ± 491 % 120min-1 , P <0.02). Cholestyramine enhanced postprandial gallbladder emptying in both obese and lean subjects. Gastric emptying was delayed with cholestyramine in lean but not obese subjects. For the chronic study, after 1 month therapy with cholestyramine (4 g every 2 days), the motility tests were repeated in nine obese subjects. Gallbladder and gastric responses to a test meal, with or without cholestyramine, were preserved. We conclude that both gallbladder and antral emptying of a liquid test meal are impaired in obese subjects. Gallbladder emptying improves after acute administration of a low dose cholestyramine with test meal. This effect is sustained after 1 month treatment with a low dose of cholestyramine and does not interfere with gastric emptying of obese patients. Cholestyramine may improve gallbladder hypomotility in obese people. 相似文献
38.
Promoting clinically effective practice: general practitioners' awareness of sources of research evidence 总被引:3,自引:1,他引:2
Prescott K; Lloyd M; Douglas HR; Haines A; Humphrey C; Rosenthal J; Watt I 《Family practice》1997,14(4):320-323
BACKGROUND: Practitioners are being encouraged to base their clinical
practice on research evidence. In order to do this, they must be aware of
and use the sources of evidence. METHODS: A questionnaire survey was
undertaken to establish GPs' awareness of research evidence in their
clinical practice and, in fundholding practices, its influence on
purchasing plans. Questionnaires were sent to 360 lead fundholders in North
Thames Region and 440 of a random sample of the remaining general
practitioners in the region for comparison. RESULTS: Questionnaires were
returned by 62% of lead fundholders and 63% of GPs in the random sample.
There was limited use of the electronic sources of clinical effectiveness.
There was greater reported awareness of published sources of research
evidence and fundholding GPs were significantly more likely to have
referred to publications summarizing research evidence. CONCLUSIONS: GPs
seem to make more use of published clinical effectiveness sources than the
electronic databases. Consequently, they need educational and technical
support if they are to make full use of the available sources of research
evidence available in other media.
相似文献
39.
40.
目的 探索如何抑制嗜酸细胞的趋化作用,选择β-趋化因子巨噬细胞炎性蛋白4(MIP4)的突变性(Met-MIP4)作为趋化因子受体3的拮抗剂,将Met-MIP4基因在原核细胞中进行表达。方法 设计MIP4基因的PCR引物并进行氨基酸突变,将MIP4N末端的丙氨酸突变为蛋氨酸,以正常人肺酸突变,将MIP4N末端的丙氨酸突变为蛋氨酸。以正常人肺cDNA文库为模板,PCR方法获取Met-MIP4基因,克隆入载体pUC19,测序验证序列已得到突变,将正确的基因插入到GST融合表达载体pGEX-4T中,以IPTG诱导表达。结果 PCR产物为220bp左右的片段,连接入pUC19质粒后测序验证获得正确突变,构建的pGEX-4T融合表达载体在大肠杆菌中表达,经SDS-PAGE凝胶电泳显示有大小约34kU的新生融合蛋白表达。结论 成功突变并克隆了β-趋化因子MIP4基因,SDS-PAGE表明,与GST融合的Met-MIP4突变体已得到表达,为进一步研究其生物学活性奠定了基础。 相似文献